Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

Share Price is delayed by 15 minutes
Get Live Data
674.00    -5.00 (-0.74%)
Bid:
672.00
Ask:
675.00
Spread: 3.00 (0.446%)
Market Cap: £1.24b
VLX Live PriceLast checked at - London Stock Exchange

Intraday Volex Share Chart

Director/PDMR Shareholding

30 Aug 2023 17:00

RNS Number : 8540K
Volex PLC
30 August 2023
 

30 August 2023

Volex plc

("Volex" or "the Company")

Director / PDMR Dealing

Volex plc (AIM:VLX) announces that on Wednesday 30 August 2023 (i) NR Holdings Ltd and Nathaniel Rothschild received 409,391 ordinary shares of 25 pence each in the capital of the Company ("Ordinary Shares"), (ii) Amelia Murillo received 504 Ordinary Shares and (iii) Sir Peter Westmacott received 16 Ordinary Shares, in each case at the reference price of 284.9 pence per share, through the scrip dividend issued on Wednesday 30 August 2023, as set out in the notification of dealing form below.

 

Following this issue, including those shares held through NR Holdings Ltd, of which Mr Rothschild is a beneficiary, Nathaniel Rothschild will be interested in 45,269,297 Ordinary Shares, representing 24.95% of the ordinary issued share capital of the Company, Amelia Murillo will be interested in 55,776 Ordinary Shares, representing 0.03% of the ordinary issued share capital of the Company, and Sir Peter Westmacott will be interested in 7,734 Ordinary Shares, representing 0.004% of the ordinary issued share capital of the Company.

 

The notification below is made in accordance with the requirements of the UK version of the EU Market Abuse Regulation which is part of English law by virtue of the European Union (Withdrawal) Act 2018.

 

1

Details of the Director / person discharging managerial responsibilities / person closely associated 

a)

Name

(i) NR Holdings Ltd and Nathaniel Rothschild

(ii) Amelia Murillo

(iii) Sir Peter Westmacott

2

Reason for the notification

a)

Position/status

(i) Executive Chairman

(ii) Non-Executive Director

(iii) Non-Executive Director

b)

Initial notification / Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

Name

Volex plc

b)

LEI

213800HBLQNH5FXXGE63

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 

a)

Description of the financial instrument, type of instrument 

Ordinary Shares of 25 pence each

Identification code 

GB0009390070

b)

Nature of the transaction

Scrip dividend issue

c)

Price(s) and volume(s) 

(i) 409,391 Ordinary Shares of 25 pence each at a price of 284.9 pence per Ordinary Share.

(ii) 504 Ordinary Shares of 25 pence each at a price of 284.9 pence per Ordinary Share.

(iii) 16 Ordinary Shares of 25 pence each at a price of 284.9 pence per Ordinary Share.

d)

Aggregated information

- Aggregated volume

See 4(c) above.

- Aggregated price

e)

Date of the transaction

30 August 2023

f)

Place of the transaction 

Outside a trading venue

 

 

 

For further information please contact:

Volex plc +44 (0)7971 156 431

Nat Rothschild, Executive Chairman

Jon Boaden, Chief Financial Officer

Chris Bedford, Group General Counsel and Company Secretary

Peel Hunt LLP ‐ Nominated Adviser & Joint Broker +44 (0)20 7418 8900

Ed Allsopp

Tom Ballard

Ben Harrington

HSBC Bank plc ‐ Joint Broker +44 (0)20 7991 8888

Simon Alexander

Joe Weaving

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEBLFXXVLEBBV
Date   Source Headline
26th May 20263:00 pmRNSNotice of Results
15th May 20267:45 amRNSHolding(s) in Company
11th May 20267:00 amRNSHolding(s) in Company
30th Apr 20263:07 pmRNSHolding(s) in Company
22nd Apr 20267:00 amRNSCapital Markets Event
7th Apr 20267:00 amRNSLaunch of £40 million Share Buyback Programme
7th Apr 20267:00 amRNSUpdate on Move to the Main Market
26th Mar 20265:30 pmRNSHolding(s) in Company
25th Mar 20267:00 amRNSTrading update and Notice of Capital Markets Event
20th Mar 20262:00 pmRNSDirector/PDMR Shareholding
10th Feb 20267:45 amRNSHolding(s) in Company
2nd Feb 20264:45 pmRNSDirector/PDMR Shareholding
30th Jan 20264:30 pmRNSDirector/PDMR Shareholding
21st Jan 20267:00 amRNSTrading Update
12th Jan 20265:30 pmRNSDirector/PDMR Shareholding
8th Jan 20262:00 pmRNSDirector/PDMR Shareholding
5th Jan 20263:00 pmRNSIssue of Equity and Total Voting Rights
15th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 20255:55 pmRNSDirector/PDMR Shareholding
4th Dec 202511:30 amRNSScrip Reference Price
12th Nov 20257:00 amRNSAppointment of Non-Executive Chair and CEO
12th Nov 20257:00 amRNSHalf-year Report
20th Oct 20257:00 amRNSNotice of Results
16th Oct 20257:00 amRNSHalf Year Trading Update
29th Sep 20251:25 pmRNSHolding(s) in Company
18th Sep 20257:00 amRNSHolding(s) in Company
15th Sep 202511:30 amRNSDirector/PDMR Shareholding
15th Sep 202510:15 amRNSHolding(s) in Company
5th Sep 20259:00 amRNSDirector/PDMR Shareholding
1st Sep 20251:00 pmRNSIssue of Equity and Total Voting Rights
7th Aug 20254:35 pmRNSResult of AGM
7th Aug 202512:30 pmRNSScrip Reference Price
7th Aug 20257:00 amRNSAGM Statement
4th Aug 20252:00 pmRNSHolding(s) in Company
7th Jul 20254:35 pmRNSPDMR / PCA Shareholding
4th Jul 202511:00 amRNSNotice of AGM and Publication of Annual Report
26th Jun 20257:00 amRNSPreliminary Group Results FY2025
2nd Jun 20257:00 amRNSNotice of Results and Investor Presentation
16th Apr 20252:00 pmRNSDirector/PDMR Shareholding
16th Apr 20251:00 pmRNSDirector/PDMR Shareholding
10th Apr 20256:00 pmRNSDirector/PDMR Shareholding
7th Apr 20257:00 amRNSFull Year Trading Update
19th Mar 20253:30 pmRNSDirector/PDMR Shareholding
13th Mar 20255:45 pmRNSHolding(s) in Company
27th Jan 20257:00 amRNSChange of Adviser
27th Jan 20257:00 amRNSTrading Update
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
3rd Jan 20257:00 amRNSDeferred Consideration for Acquisition
19th Dec 20247:00 amRNSForm 8.3 - Volex PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.